It is known that 5-FU treatment in CRC promotes apoptosis through caspase-9 activation [34], here we investigated if the addition of the AntagomiR-675-5p promotes cell death by enforcing cell entrance into apoptosis. Here, CASP9 is linked to colorectal carcinoma.